Brookfield Corp’s Barinthus Biotherapeutics BRNS Stock Holding History

Brookfield Corp’s Portfolio BRNS Stock Details BRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-15,921	Closed	-$251K	–	640
2021 Q3	$251K	Sell	15,921 -9,079	-36%	-$138K	﹤0.01%	490
2021 Q2	$420K	Buy	+25,000	New	+$370K	﹤0.01%	509

Other funds holding BRNS

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return

Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return

BlueCrest Capital Management St Helier, Jersey $1.06B AUM 20.01% 1-Year Est. Return

Johns Hopkins University Baltimore, Maryland $1.38B AUM 9.48% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Ipswich Investment Management Beverly, Massachusetts $426M AUM 24.58% 1-Year Est. Return

Hudson Bay Capital Management

Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return

Arena Capital Advisors Los Angeles, California $200M AUM 23.6% 1-Year Est. Return

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return